Fourth and final issue of GaBI Journal’s 10th volume
Extended stability of the trastuzumab biosimilar ABP 980 (KANJINTI™) in polyolefin bags and elastomeric devices
The European framework for intellectual property rights for biological medicines
Biotechnological therapies and biosimilars for COVID-19: scarcities, poor regulation, and pharmaceutical black market: a case analysis in Ecuador
Source URL: http://gabi-journal.net/2021-4-gabi-journal-table-of-contents.html
Copyright ©2022 GaBI Journal unless otherwise noted.